INTRODUCTION {#sec1}
============

Community-acquired pyogenic liver abscess (CA-PLA) caused by hvKP with haematogenous metastatic infection of extrahepatic sites such as lungs and central nervous system has been described in East (E) and South East (SE) Asia and is recognized as an emerging infection worldwide.

We report a fatal case caused by a multiply antibiotic resistant strain of hvKP in a previously well man.

CASE REPORT {#sec2}
===========

A 47-year-old man presented to the Emergency Department of a tertiary care hospital with a 4-week history of fever, fatigue, myalgia, abdominal pain and dry cough that had become worse in the week prior to admission.

He was Nigerian, living in the UK. He had last visited Nigeria 4 months earlier and had taken antimalarial prophylaxis. He had type 2 diabetis mellitus (DM) and hypertension but was otherwise well.

Investigations showed early organ impairment, with mild liver enzyme elevation, acute kidney injury, raised white cell count and C-reactive protein (Table [1](#TB1){ref-type="table"}). Although a chest radiograph performed at the same time appeared clear (Fig. [1](#f1){ref-type="fig"}), the patient's presentation was ascribed to a lower respiratory tract infection and he was discharged with oral co-amoxiclav.

###### 

Blood results taken throughout the duration of the patients stay

  Investigation performed                 Date                                
  --------------------------------------- ------- -- ------- ---------------- -------
  CRP (\<5 mg/L)                          72         407.5   378.3            418.6
  Na (135--145 mmol/L)                    132        133     147              143
  K (3.5--5.0 mmol/L                      3.8        3.8     4.1              
  Creat (45--120 umol/L)                  104        103     94               74
  Urea (3.3--6.7 mmol/L)                  4.7        7.8     7.4              5.9
  eGFR (ml/min)                           66         67      75               \>90
  Bili (3--20 umol/L)                     39         61      73               70
  ALK Phos (30--130 IU/L)                 82         138     227              293
  AST (10--50 IU/L)                       82         353     783              
  HB (130 -- 165 g/L)                     141        139     114              111
  WCC (4--11 10^9^/L)                     13.81      10.06   6.05             5.62
  Neutrophils (2.2--6.3 10^9^/L)          12.25      9.00    4.63             4.33
  PLT (150--450 10^9^/L)                  130        29      16               48
  INR (0.9--1.20 ratio)                   1.14       2.21    1.71             1.69
  APTTR (0.85--1.15 ratio)                1.06       1.42    1.17             1.16
  CEA (\<5 ug/L)                                     \<2                      
  Ca199 (\<37 kU/L)                                  5                        
  AFP (\<7 kIU/L)                                    \<2                      
  LDH (\<240 IU/L)                                   576                      
  HBA1c (4.1--6.0%)                                  9                        
  BDG (\<8 pg/ml)                                            Negative         
  IgG (6.34--18.11 g/L)                                      9.55             
  IgM (0.53--2.23 g/L)                                       2.75             
  IgA (0.87--4.12 g/L)                                       0.74             
  Total protein (60-80 g/L)                                  51               
  Nuclear antibodies                                         Negative         
  Anti-gastric parietal cell antibodies                      Negative         
  Liver Kidney Microsomal Antibodies                         Negative         
  Anti-smooth muscle antibodies                              Negative         
  MITO                                                       Negative         
  Cardiolipin IgG (\<10 GPL U/ml)                            3.1              
  Cardiolipin IgM (\<10 MPL U/ml)                            2.7              
  Ferritin (20-300ug/L)                                      8191             
  PSA (\<2.5ug/L)                                            4.3              
  Cholesterol (1.0--5.0 mmol/L)                              3.5              
  Triglyceride (0.5--2.0 mmol/L)                             6.1              
  ANCA                                                       Negative         
  Complement C3 (0.75--1.65 g/L)                             0.34             
  Complement C4 (0.16--0.54 g/L)                             0.07             
  DS DNA Ab (\<10 IU/ml)                                     3 (Negative)     
  Anti-GBM Ab (\<7 U/ml)                                     2.2 (Negative)   

AFP - Alpha -- Fetoprotein, ALK Phos - Alkaline Phosphatase, ANCA - Antineutrophil cytoplasmic antibodies, Anti-GBM Ab - Anti-glomerular basement membrane antibodies, APTTR - Activated partial thromboplastin time ratio, AST - Aspartate transaminase, BDG - Beta d glucan, Bili - Bilirubin, Ca199 - Pancreatic tumour antigens CA19--9, Cardiolipin IgG - Cardiolipin immunoglobulin G, Cardiolipin IgM - Cardiolipin immunoglobulin M, CEA - Carcinoembryonic antigen, Complement C3 - Complement component 3, Complement C4 - Complement component 4, Creat - Creatinine, CRP - C-reactive protein, DS DNA Ab - Double Stranded DNA antibodies, eGFR - Estimated glomerular filtration rate, Hb - Haemoglobin, HBA1c - Glycated haemoglobin, IgA - Immunoglobulin A, IgG - Immunoglobulin G, IgM - Immunoglobulin M, INR - International normalised ratio, K - Potassium, LDH - Lactate dehydrogenase, MITO - Anti-mitochondrial antibodies, Na - Sodium, PLT - Platelets, PSA - Prostate specific antigen, WCC - White cell count.

###### 

Microbiology results taken throughout the course of the patients stay

  Investigation Performed       Date                                                                                                                                                                                                        
  ----------------------------- -------------------------------------------------------- --------------------------------------------------- --------------------------------------------------------------------- ------------- ---------- ----------------------------------------
  Blood culture                 +ve for *K. pneumoniae* Co-amox -- R Gent---S Mero---S                                                                                                                                                      
  Blood culture                                                                          +ve for K. pneumoniae Cipro---S Gent---S Mero---S                                                                                                  
  HIV                                                                                    Negative                                                                                                                                           
  Mid-stream urine                                                                       Negative                                                                                                                                           
  Sputum culture                                                                                                                             +ve for K. pneumoniae Co-amox -- R Taz -- R Mero---S ESBL producing                            
  Resp. Viral screen                                                                                                                         Negative                                                                                       
  HIV                                                                                                                                        Negative                                                                                       
  Blood culture                                                                                                                              Negative                                                                                       
  Hepatitis B                                                                                                                                Negative                                                                                       
  Hepatitis C                                                                                                                                Negative                                                                                       
  Hepatitis A                                                                                                                                Negative                                                                                       
  Hepatitis B                                                                                                                                Negative                                                                                       
  Hepatitis C                                                                                                                                Negative                                                                                       
  CMV                                                                                                                                        Negative                                                                                       
  EBV                                                                                                                                        Negative                                                                                       
  BDG (\<8 pg/ml)                                                                                                                                                                                                  Negative                 
  CMV (copies/ml)                                                                                                                                                                                                  \<10 copies              
  EBV (copies/ml)                                                                                                                                                                                                  \<10 copies              
  Adenovirus (copies/ml)                                                                                                                                                                                           \<10 copies              
  Aspergillus EIA                                                                                                                                                                                                  Negative                 
  MRSA screen                                                                                                                                                                                                      Negative                 
  HTLV 1                                                                                                                                                                                                           Negative                 
  HTLV 2                                                                                                                                                                                                           Negative                 
  Toxoplasma IgG                                                                                                                                                                                                   Negative                 
  Treponemal Serology                                                                                                                                                                                              Negative                 
  EBV VCA IgG (past exposure)                                                                                                                                                                                      Positive                 
  CMV IgG                                                                                                                                                                                                          Positive                 
  Candida Auris Screen                                                                                                                                                                                                           Negative   
  TB Sputum screen                                                                                                                                                                                                                          Negative -- acid fast bacilli not seen

Aspergillus EIA - Aspergillus enzyme immunoassay, BDG - Beta D Glucan, Cipro - Ciprofloxacin, CMV - Cytomegalovirus, CMV IgG - Cytomegalovirus Immunoglobulin G, Co-amox - Co-amoxiclav, EBV - Epstein-Barr virus, EBV VCA IgG - Epstein-Barr Virus viral capsid antigen Immunoglobulin G, ESBL producing - Extended-spectrum beta-lactamase producing organism, Gent - Gentamicin, HIV - Human Immunodeficiency Virus, HTLV 1- Human T-lymphotropic virus 1, HTLV 2 - Human T-lymphotropic virus 2, Mero - Meropenem, MRSA - Methicillin-Resistant *Staphylococcus aureus*, R - Resistant, Resp. viral screen - Respiratory viral screen, S - Sensitive, Taz - Piperacillin + Tazobactam, TB sputum screen - Tuberculosis sputum screen, Toxoplasma IgG - Toxoplasma Immunoglobulin G.

![Frontal Chest Radiograph (on presentation): The lungs are clear. No pleural effusion. Cardiomediastinal contour are unremarkable.](omz032f1){#f1}

The following day, blood cultures were positive with Gram negative rods seen on microscopy.

He was admitted and treated with ceftriaxone and gentamicin. He complained of breathlessness and pleuritic chest pain. D-dimer was positive. He underwent a CT pulmonary angiogram and contrast CT of abdomen and pelvis.

Pulmonary embolism was excluded but there were multifocal changes in the right lung consistent with infection. A 6-cm liver abscess was seen in the right lobe (Figs. [2](#f2){ref-type="fig"}--[4](#f4){ref-type="fig"}).

![CT Abdomen (Portal Venous phase). Axial image (Figure [2](#f2){ref-type="fig"}) and Coronal (Figure [3](#f3){ref-type="fig"}): there is a 6 cm lobulated mass located in the right lobe of the liver with peripheral enhancement and areas of central necrosis (gas) consistent with abscess formation. The remainder of the liver was normal, in particular, no portal or hepatic vein thrombosis.](omz032f2){#f2}

![CT Abdomen (Portal Venous phase). Axial image (Figure [2](#f2){ref-type="fig"}) and Coronal (Figure [3](#f3){ref-type="fig"}): there is a 6 cm lobulated mass located in the right lobe of the liver with peripheral enhancement and areas of central necrosis (gas) consistent with abscess formation. The remainder of the liver was normal, in particular, no portal or hepatic vein thrombosis.](omz032f3){#f3}

![CT pulmonary angiogram. Axial image (lung windows): there is nodular right upper lobe air space opacification with surrounding ground glass nodules noted. No lung abscess demonstrated.](omz032f4){#f4}

The Gram negative rods were identified as KP, resistant to co-amoxiclav, ceftriaxone and piperacillin-tazobactam, but susceptible to gentamicin and meropenem. Extended spectrum beta-lactamase (ESBL) production was confirmed. Table [2](#TB2){ref-type="table"} shows the microbiology results taken throughout the course of the patients stay. The patient was transferred to intensive care because of multi-organ failure secondary to sepsis with a serum lactate of 10 mmol/L. He was agitated and complaining of headache and was intubated and ventilated. Continuous veno-venous haemoflitration was initiated. A plain chest radiograph showed progressive right middle zone consolidation (Fig. [5](#f5){ref-type="fig"}).

![Frontal chest radiograph. Central lines and tubes appropriately sited. There is loss of volume of the right lung with elevation of the right hemi-diaphragm and air space opacification of the lateral aspect of the right mid zone. Left lung is clear.](omz032f5){#f5}

Antibiotics were switched briefly to piperacillin--tazobactam but then to meropenem.

Liver ultrasound showed that the collection was predominantly solid with a central gaseous component, not amenable to surgical or radiological drainage.

Over the next 48 hours, the patient continued to deteriorate with worsening multi-organ dysfunction. Investigations for other causes of synthetic liver dysfunction were negative (Table [1](#TB1){ref-type="table"}).

He was noted to have fixed dilated pupils. CT head showed generalized oedema and a CT venogram/post contrast CT showed progressive cerebellar herniation but no abscess. Venous thrombosis could not be excluded and there was debris within the right ventricle suggestive of infection (Figs. [6](#f6){ref-type="fig"}--[9](#f9){ref-type="fig"}).

![CT head (non-contrast). Axial image: There is cerebral sulcal effacement of both hemispheres at the convexity in keeping with cerebral oedema.](omz032f6){#f6}

![CT head (non-contrast). Sagittal Image: there is preservation of the suprasellar and pre pontine/pre medullary cisterns. The cerebellar tonsils are above foramen magnum.](omz032f7){#f7}

![CT head (contrast). Axial Image: there is lateral ventricular dilatation, asymmetric to the right with evidence of debri in the occipital horn of the right lateral ventricle.](omz032f8){#f8}

![CT Head (Post Contrast). Sagittal image: There is progressive effacement of the suprasellar, pre pontine/ pre medullary cisterns with inferior cerebellar tonsillar descent below foramen magnum.](omz032f9){#f9}

The patient was too unstable for head magnetic resonance imaging (MRI) or lumbar puncture and had a cardiac arrest. Echocardiography demonstrated global hypokinesia but no severe impairment or vegetations.

He failed to demonstrate brainstem reflexes over a 4-hour sedation hold. He had two further cardiac arrests. He could not be resuscitated from a fourth despite ongoing aggressive fluid and inotropic support and died in early on the fourth day of admission.

Reference Laboratory analysis of the isolate confirmed capsular type K2 and the presence of regulator of mucoid phenotype genes rmpA and rmpA2, associated with enhanced expression of capsular polysaccharide and the hypermucoviscous phenotype

DISCUSSION {#sec4}
==========

CA-PLA with metastatic infection caused by hvKP in previously well hosts has been described in the Asia-Pacific region for many years and is recognized as an emerging infection globally ([@ref1], [@ref2]). Extrahepatic infections reported include pneumonia, endopthalmitis and meningitis.

HvKP strains are typically capsular type K1 or K2. The polysaccharide capsule is antiphagocytic and confers serum resistance. Hypervirulence is strongly (but not exclusively) associated with the hypermucoviscous phenotype, expression of which is mediated by upregulation of capsular polysaccharide synthesis by regulator of mucoid phenotype genes rmpA and rmpA2 ([@ref3], [@ref4]).

HvKP strains have been significantly less likely than non-hvKP to be resistant to multiple antibiotics. Zhang *et al*. ([@ref5]) found ESBL production in 12.6% of hvKP compared with 42% of 'typical' strains (*P* = \< 0.001).

Multi drug-resistant, hypervirulent, *Klebsiella pneumoniae* (mdrhvKP) infections are increasingly reported. A single centre study of community and healthcare-associated KP bloodstream infections by Li *et al*. ([@ref6]) found high rates of resistance to third generation cephalosporin and fluoroquinolones (\~60%) in hvKP and carbapenemase production in 20%. A nonfatal case of CA-PLA caused by ESBL-producing hvKP without metastatic complications has been reported from Taiwan ([@ref7]).

Outside E Asia mdrhvKP strains causing CA-PLA have not been seen. In case series where antimicrobial susceptibilities were reported, none of the community-acquired hvKP infections (which included 12 PLA) were caused by antibiotic resistant strains ([@ref4], [@ref8]).

Putative risk factors for CA-PLA caused by hvKP from areas outside E Asia include DM, male gender and recent travel.

It is unclear whether Asian ethnicity is an independent risk factor. Prevalence of faecal carriage of KP (including K1 and K2 strains) in healthy populations in E Asia is higher than in European populations. Dietary or environmental exposures that affect gut colonization and subsequent invasive infection with hvKP remain undefined ([@ref2], [@ref4]).

DM was significantly more common in patients with hvKP infections compared with those caused by 'typical' KP in China ([@ref5], [@ref6]). In CA-PLA caused by hvKP the prevalence of DM is 40--65% ([@ref2]).

Male predominance has been more marked in cases reported outside E Asia, up to 88% ([@ref9]). The role of recent travel and potential exposure to hvKP in the pathogenesis of CA-PLA remains unclear.

Mortality from hvKP CA-PLA is low (≤10%) but almost all reported infections have been caused by antibiotic susceptible strains. Early administration of effective antibiotics is known to reduce mortality in sepsis.

Lee *et al*. ([@ref10]) found metastatic infection was significantly associated with infection caused by rmpA positive strains, an APACHE II score of ≥20 and septic shock in 110 cases of hvKP CA-PLA. Mortality was associated with metastatic infection and gas within the abscess, features present in our case, and acute respiratory failure.

CONCLUSION {#sec5}
==========

The potential for severe sepsis and metastatic infection caused by hvKP infection and the possibility of antimicrobial resistance should be considered early in patients presenting with CA-PLA.

Further epidemiological studies are needed to elucidate risk factors for this infection.
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